C075 Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemia: Topline Efficacy and Safety Results from the Pivotal AUGMENT-101 Phase 2 Study

Abstract | Sep 23, 2024

Author

Papayannidis C, et al.

Congress

Italian Society of Hematology (SIE)

Milan, Italy | Sep 23 – 25, 2024